“Development and Evaluation of a Chitosan-based Topical Gel of Dinalbuphine sebacate for Targeted Management of Rheumatoid Arthritis” (2025) Asian Journal of Pharmaceutics (AJP), 19(2). doi:10.22377/ajp.v19i2.6471.